High expression of DSB repair-related genes (MRE11A, Rad50, RAD51, and XRCC2) in HNSCC patients may contribute to tumor acquisition and progression or induce drug-resistant phenotypes (15). The gene discussed is XRCC2; the disease is head and neck squamous cell carcinoma.